: CureVac’s COVID-19 vaccine shows immune response in Phase 1 trial 1 de novembro de 2020 by r4ibom in Uncategorized German biotech CureVac said advanced clinical trials are on track to launch by the end of 2020. Compartilhe isso:Clique para compartilhar no Twitter(abre em nova janela)Clique para compartilhar no Facebook(abre em nova janela) Relacionado 1 de novembro de 2020
